PROTEINS CAPABLE OF TRIGGERING G2/M TRANSITION AND OF INTERACTING WITH CDC2- AND CYCLIN B - Patent 1144627

(19)

(11)

EP 1 144 627 A2

(12)

(43)	Date of publication:
	17.10.2001 Bulletin 2001/42

(21)	Application number: 00907496.4

(22)	Date of filing: 03.02.2000

(51)	International Patent Classification (IPC)⁷: C12N 15/12, C12N 15/62, C07K 14/46, A61K 38/17, A61P 15/00, A61P 35/00, G01N 33/50, G01N 33/68, C12Q 1/68

(86)	International application number:
	PCT/EP0000/877

(87)	International publication number:
	WO 0046/367 (10.08.2000 Gazette 2000/32)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

03.02.1999 EP 99102172

(71)	Applicant: EUROPÄISCHES LABORATORIUM FÜRMOLEKULARBIOLOGIE (EMBL)
	D-69117 Heidelberg (DE)

(72)	Inventors:
	FERBY, Ingvar, Mats D-69115 Heidelberg (DE) NEBREDA, M., Angel Rodriguez D-69251 Gaiberg (DE)

(74)	Representative: Böhm, Brigitte, Dipl.-Chem. Dr. et al
	Weickmann & WeickmannPatentanwältePostfach 860 820 81635 München 81635 München (DE)


	Remarks:
	WIPO A3 publication data is not currently available.

(54)	PROTEINS CAPABLE OF TRIGGERING G2/M TRANSITION AND OF INTERACTING WITH CDC2- AND CYCLIN B